Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)

NCT01471379 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Due to recruitment difficulties the study is terminated.

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Milnacipran
DRUG: Milnacipran
DRUG: Milnacipran
DRUG: Placebo

Sponsor

Spencer Dorn, MD, MPH

Collaborators

[object Object]